Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.1 | - |
NAV | ₹29.01 | - |
Fund Started | 04 Dec 2015 | - |
Fund Size | ₹1310.50 Cr | - |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹29.01
-
Fund Started
04 Dec 2015
-
Fund Size
₹1310.50 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year | -3.96% | - |
3 Year | 20.52% | - |
5 Year | 13.76% | - |
1 Year
-3.96%
-
3 Year
20.52%
-
5 Year
13.76%
-
Equity | 98.68% | - |
Cash | 1.32% | - |
Equity
98.68%
-
Cash
1.32%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.88% |
Max Healthcare Institute Ltd. | 5.87% |
Abbott India Ltd. | 5.48% |
Divi's Laboratories Ltd. | 5.01% |
Healthcare Global Enterprises Ltd. | 4.84% |
Apollo Hospitals Enterprise Ltd. | 4.76% |
Cipla Ltd. | 4.14% |
Rainbow Children's Medicare Ltd. | 3.77% |
Ipca Laboratories Ltd. | 3.72% |
JB Chemicals & Pharmaceuticals Ltd. | 3.52% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | - |
Launch Date | 04 Dec 2015 | - |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-